Insider · CIK 0001748961

Agresta Samuel

Reports to the SEC for 3 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001748961

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+131K sh	—	—	131,396
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+50K sh	—	—	50,000
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−18.6K sh	—	—	0
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+18.6K sh	—	—	18,588
2026-08-07	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−131K sh	—	—	0
2026-04-01	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+110K sh	—	—	110,000
2025-01-27	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+45K sh	—	—	45,000
2024-10-04	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+131K sh	—	—	131,396
2024-10-04	OKUROnKure Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+18.6K sh	—	—	18,588
2023-08-16	FHTXFoghorn Therapeutics Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+311K sh	$3.72	+$1.16M	311,297
2023-08-16	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−311K sh	—	—	0
2023-08-16	FHTXFoghorn Therapeutics Inc.S Sale	Chief Medical Officer	SSale	−311K sh	$8.25	−$2.57M	0
2023-01-26	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+60K sh	—	—	60,000
2022-06-16	INFINITY PHARMACEUTICALS, INC.Stock Option(right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2022-01-26	FHTXFoghorn Therapeutics Inc. · Stock Option (right to buy)A Award	Chief Medical Officer	AAward	+125K sh	—	—	125,000
2021-06-10	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2021-01-28	FHTXFoghorn Therapeutics Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000
2020-10-16	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2020-06-17	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2019-01-04	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+62.6K sh	—	—	62,596
2018-08-06	INFINITY PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Director	AAward	+300K sh	—	—	300,000

Recent filings

Accepted (ET)
Aug 114
Agresta Samuel0001748961-26-000002
SEC(opens sec.gov)
Apr 34
Agresta Samuel0001748961-26-000001
SEC(opens sec.gov)
Jan 294
Agresta Samuel0001415889-25-002309
SEC(opens sec.gov)
Oct 84
Agresta Samuel0001415889-24-024911
SEC(opens sec.gov)
Aug 184
Agresta Samuel0001562180-23-006433
SEC(opens sec.gov)
Jan 304
Agresta Samuel0001562180-23-000728
SEC(opens sec.gov)
Jun 164
Agresta Samuel0001140361-22-023318
SEC(opens sec.gov)
Jan 284
Agresta Samuel0001562180-22-000751
SEC(opens sec.gov)
Jun 114
Agresta Samuel0001140361-21-020649
SEC(opens sec.gov)
Feb 14
Agresta Samuel0000899243-21-003968
SEC(opens sec.gov)
Jun 184
Agresta Samuel0000899243-20-017000
SEC(opens sec.gov)
Oct 164
Agresta Samuel0000899243-19-025628
SEC(opens sec.gov)
Jan 74
Agresta Samuel0000899243-19-000654
SEC(opens sec.gov)

Companies

Address

C/O ONKURE THERAPEUTICS, INC. 6707 WINCHESTER CIRCLE, SUITE 400

BOULDER, CO, 80301